Dürr, P.; Meier, F.; Schlichtig, K.; Schramm, A.; Schötz, L.; Fromm, M.F.; Dörje, F.
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial. J. Clin. Med. 2022, 11, 6392.
https://doi.org/10.3390/jcm11216392
AMA Style
Dürr P, Meier F, Schlichtig K, Schramm A, Schötz L, Fromm MF, Dörje F.
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial. Journal of Clinical Medicine. 2022; 11(21):6392.
https://doi.org/10.3390/jcm11216392
Chicago/Turabian Style
Dürr, Pauline, Florian Meier, Katja Schlichtig, Anja Schramm, Lukas Schötz, Martin F. Fromm, and Frank Dörje.
2022. "Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial" Journal of Clinical Medicine 11, no. 21: 6392.
https://doi.org/10.3390/jcm11216392
APA Style
Dürr, P., Meier, F., Schlichtig, K., Schramm, A., Schötz, L., Fromm, M. F., & Dörje, F.
(2022). Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial. Journal of Clinical Medicine, 11(21), 6392.
https://doi.org/10.3390/jcm11216392